<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04847024</url>
  </required_header>
  <id_info>
    <org_study_id>2019-523</org_study_id>
    <nct_id>NCT04847024</nct_id>
  </id_info>
  <brief_title>Parecoxib vs. Dexketoprofen for the Management of Pain After Cesarean Section.</brief_title>
  <official_title>Parecoxib vs. Dexketoprofen in Combination With Acetaminophen as Additional Analgesia in Patients With Neuraxial Morphine for the Management of Pain After Cesarean Section. A Randomized, Double Blind, Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Thomas Hospital, Panama</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Saint Thomas Hospital, Panama</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although it is known that parecoxib and dexketoprofen are commonly used in successful&#xD;
      post-operative pain relief, there are very few studies that compare these two agents in their&#xD;
      individual applications and/or combined with neuraxial analgesia with opioids and even less&#xD;
      in post-cesarean section pain, as well as the evaluation of the side effects and their impact&#xD;
      on the patient's functionality. For this reason, in order to approach this answer, we sought&#xD;
      to perform this study in patients undergoing elective or emergency cesarean section in our&#xD;
      institution, who meet the inclusion criteria, using the Visual Analog Pain Scale at 12 hrs&#xD;
      and 24 hrs post surgery and evaluating the aforementioned side effects, comparing in one arm&#xD;
      of the study Parecoxib + acetaminophen vs Dexketoprofen + acetaminophen in the other arm,&#xD;
      randomizing the patients in both groups using a double-blind configuration.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 1, 2019</start_date>
  <completion_date type="Actual">September 30, 2019</completion_date>
  <primary_completion_date type="Actual">September 30, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Parecoxib + acetaminophen vs Dexketoprofen + acetaminophen in patient receiving neuraxial analgesia for pain after caesarean section.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain at 12 hours</measure>
    <time_frame>12 hours</time_frame>
    <description>Evaluation of pain using the Visual Analogue Scale (from 0 to 10, where 0 is no pain and 10 is the most terrible pain imaginable)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain at 24 hours</measure>
    <time_frame>24 hours</time_frame>
    <description>Evaluation of pain using the Visual Analogue Scale (from 0 to 10, where 0 is no pain and 10 is the most terrible pain imaginable)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>24 hours</time_frame>
    <description>Side effects associated with the drug used (Dexketoprofen vs. Parecoxib)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">380</enrollment>
  <condition>Caesarean Section; Pain</condition>
  <arm_group>
    <arm_group_label>Parecoxib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Parecoxib 40 mg reconstituted in 2ml of saline solution, to pass IV as a bolus, every 12hrs + acetaminophen 1g in 100cc of saline solution to pass IV in 15 minutes, every 6hrs.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexketoprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexketoprofen 50 mg in 100 cc of saline solution, protected from sunlight, to be given IV in 15 minutes, every 8hrs + acetaminophen 1g in 100 cc of saline solution to be given IV in 15 minutes, every 6hrs.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Parecoxib</intervention_name>
    <description>40 mg IV</description>
    <arm_group_label>Parecoxib</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexketoprofen</intervention_name>
    <description>50 mg IV</description>
    <arm_group_label>Dexketoprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Pregnancy 32w or more.&#xD;
&#xD;
          -  Emergency or elective caesarean section.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Allergy to Parecoxib.&#xD;
&#xD;
          -  Allergy to dexketoprofen.&#xD;
&#xD;
          -  Allergy to acetaminophen.&#xD;
&#xD;
          -  General anesthesia.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Gender identity</gender_description>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Saint Thomas H</name>
      <address>
        <city>Panama</city>
        <country>Panama</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Panama</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 13, 2021</study_first_submitted>
  <study_first_submitted_qc>April 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">April 15, 2021</study_first_posted>
  <last_update_submitted>October 4, 2021</last_update_submitted>
  <last_update_submitted_qc>October 4, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Saint Thomas Hospital, Panama</investigator_affiliation>
    <investigator_full_name>Osvaldo A. Reyes T.</investigator_full_name>
    <investigator_title>Coordinator of research</investigator_title>
  </responsible_party>
  <keyword>Caesarean section</keyword>
  <keyword>Pain</keyword>
  <keyword>Parecoxib</keyword>
  <keyword>Dexketoprofen</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Parecoxib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

